Accentus Medical, a global leader in silver-based anti-microbial implant surfaces, is pleased to announce the appointment of Brian Howlett and Laurie Rostron to its board of directors.
News
Acusure® Technology gains further approval for use in the USA
Accentus Medical is pleased to announce that one of its customers, FHi, a member of the FH Orthopedics Group, recently gained a 510(K) approval from the US Food and Drug Administration for its Arrow Reverse Total Shoulder prosthesis. This product incorporates the proprietary Acusure® inert gas plasma spray coating, applied by Accentus Medical at our facility in Harwell.
Accentus Medical innovation recognised at Oxfordshire Business Awards
Accentus Medical has been recognised as a successful innovation company at the 2012 Oxfordshire Business Awards.
Accentus Medical anti-infective Agluna® technology awarded CE mark as component of Stanmore Implants METS tumour replacement system
Accentus Medical announced today that the first medical device to incorporate its Agluna® silver anti-infective technology has received a European CE mark.
Accentus Medical Set for Further Growth
Accentus Medical announced today that it has successfully completed the installation and initial demonstration of a prototype manufacturing plant for its Agluna® anti-infective technology, following the award of a grant worth £330,000 from the Technology Strategy Board within the High Value Manufacturing call.